Rob Dillard

Articles by Rob Dillard

Rob DillardAHA 2024 | December 3, 2024
Individuals with cardiac implantable electronic devices have a higher risk of tricuspid regurgitation.
Read More
Rob DillardAHA 2024: CardioNerds | November 27, 2024
The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
A case study highlights the importance of avoiding anchoring bias in the diagnosis of cardiac amyloidosis.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
The diagnosis of AL amyloidosis requires a high index of suspicion to render a prompt diagnosis and appropriate treatment.
Rob DillardAHA 2024 | November 25, 2024
Mortality rates among inpatients with HF who undergo AF catheter ablation are relatively low.
Rob DillardAHA 2024 | November 25, 2024
BC survivors undergoing CIED placement have a higher risk of periprocedural complications.
Rob DillardAHA 2024 | November 25, 2024
There have been dramatic improvements in remote monitoring among both urban and rural patients with CIED.
Rob DillardAHA 2024 | November 25, 2024
LAAO in elderly patients with atrial fibrillation demonstrates similar efficacy to those seen in younger patients.
Rob DillardMelanoma | November 21, 2024
Remote analysis of cancerous-looking skin growths yields the same level of accuracy as in-person analysis.
Anne Marie Morse, DOSleep Disorders | November 21, 2024
Dr. Anne Marie Morse talks about parasomnias, and how they affect quality of life in people who have them.
Rob DillardAHA 2024: CardioNerds | November 20, 2024
A study further supports the efficacy of acoramidis in the treatment of people with ATTR-CM.
Dr. Shaun GrannisRSV | November 19, 2024
Dr. Shaun Grannis talks about a large-scale study which showed the robust efficacy of RSV vaccine in older adults.
Rob DillardAHA 2024 | November 15, 2024
For patients with CIEDs who undergo remote monitoring, routine in-person visits may not be needed.
Rob DillardAHA 2024 | November 15, 2024
Researchers assessed the safety of rides for patients with cardiac implantable electronic devices.
Rob DillardAHA 2024 | November 15, 2024
Frailty significantly increases the risk of both in-hospital mortality, and complications in HFrEF patients following CIED.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
People with amyloidosis have a significantly higher prevalence of atrial fibrillation.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
An AI model for detecting ATTR-CA yields solid diagnostic results.
Rob DillardAHA 2024: CardioNerds | November 18, 2024
On average, the readability of patient educational materials on cardiac amyloidosis fails to meet NIH standards.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
A deep-learning model is able to detect ATTR-CM with robust efficacy.
Rob DillardAHA 2024: CardioNerds | November 15, 2024
Practical strategies are needed in health centers to ensure patients with ATTRv receive optimal care.